Internal Server Error

List of BioMerieux's Acquisitions

lockFilter this list
BioMerieux has made a total of 16 acquisitions. These transactions span 10 sectors, such as Genomics, Infectious Diseases, and Life Sciences Platforms and Tools, across 8 countries, led by United States, France, and China. Peak activity occurred in 2008, 2016, and 2018, with 2 acquisitions each. Between 2020 and 2025, the company averaged 0.6 acquisitions per year, followed by 1 acquisition in the current calendar year. The most recent acquisition is Accellix, a San Jose-based developer of an immunotherapy-based assay delivery platform founded in 2007, which was finalized in January 2026.

Here's the year on year acquisition history of BioMerieux:

Year on year acquisition history of BioMerieux202620252024202220192018Acquisitions Round Date (Yearly)0123
  • Number of Total Acquisitions
Year
# Acquisitions
2026
1
2025
1
2024
1
2022
1
2019
1
2018
2
2016
2
2014
1
2013
1
2012
1
2011
1
2008
2
2006
1

Recent acquisitions by BioMerieux

BioMerieux's most recent acquisition - Accellix is a Developer of immunotherapy-based assay delivery platform, founded in 2007 and located in San Jose. BioMerieux acquired it in January 2026 for a price of $*****.

Here is the list of all acquisitions by BioMerieux sorted by the latest acquisition date:

Acquired on
Acquired Company
Acquisition Price
Facilitators
Stake Acquired
Acquisition Multiple
Jan 22, 2026
coss
hryu
86
215
Jan 13, 2025
dn{n
acux
14
691
Jan 11, 2024
mbdh
ojes
48
805
Apr 12, 2022
lrrx
bejw
74
465
Feb 07, 2019
{lqw
aqkq
50
361

View the full list of acquisitions

Sign Up for Free

News related to BioMerieux's acquisitions

lockFilter this list

Media has covered BioMerieux for a total of 11 events in the last 1 year, 2 of them have been about acquisition activity.

View More BioMerieux Recent News

FAQs about Acquisitions by BioMerieux

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford